Full Product Name
CTNS Antibody (C-term)
Product Synonym Names
Cystinosin; CTNS
Product Gene Name
anti-CTNS antibody
[Similar Products]
Antibody/Peptide Pairs
CTNS peptide (MBS9224286) is used for blocking the activity of CTNS antibody (MBS9215258)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Immunogen Sequence Positions
341-367
3D Structure
ModBase 3D Structure for O60931
Specificity
This CTNS antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 341-367 amino acids from the C-terminal region of human CTNS.
Purity/Purification
Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
Form/Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Concentration
Vial Concentration: 0.5 (lot specific)
Antigen Type
Synthetic Peptide
Preparation and Storage
Maintain refrigerated at 2-8 degree C for up to 6 months. For long term storage store at -20 degree C in small aliquots to prevent freeze-thaw cycles.
Other Notes
Small volumes of anti-CTNS antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-CTNS antibody
This gene encodes a seven-transmembrane domain protein
that functions to transport cystine out of lysosomes. Its activity
is driven by the H+ electrochemical gradient of the lysosomal
membrane. Mutations in this gene cause cystinosis, a lysosomal
storage disorder. Alternative splicing results in multiple
transcript variants.
Product Categories/Family for anti-CTNS antibody
Metabolism; Signal Transduction
Applications Tested/Suitable for anti-CTNS antibody
Western Blot (WB), ELISA (EIA)
Application Notes for anti-CTNS antibody
WB~~1:1000
Western Blot (WB) of anti-CTNS antibody
CTNS Antibody (C-term) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the CTNS antibody detected the CTNS protein (arrow).

NCBI/Uniprot data below describe general gene information for CTNS. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001026851.2
[Other Products]
NCBI Related Accession #
HumanNP_004928.2[Other Products]
NCBI GenBank Nucleotide #
NM_001031681.2
[Other Products]
UniProt Primary Accession #
O60931
[Other Products]
UniProt Secondary Accession #
Q8IZ01; Q9UNK6; D3DTJ5[Other Products]
UniProt Related Accession #
O60931[Other Products]
NCBI Official Full Name
cystinosin isoform 1
NCBI Official Synonym Full Names
cystinosin, lysosomal cystine transporter
NCBI Official Symbol
CTNS [Similar Products]
NCBI Official Synonym Symbols
PQLC4; CTNS-LSB
[Similar Products]
NCBI Protein Information
cystinosin
UniProt Protein Name
Cystinosin
Protein Family
Cystinosin
UniProt Gene Name
CTNS [Similar Products]
UniProt Entry Name
CTNS_HUMAN
NCBI Summary for CTNS
This gene encodes a seven-transmembrane domain protein that functions to transport cystine out of lysosomes. Its activity is driven by the H+ electrochemical gradient of the lysosomal membrane. Mutations in this gene cause cystinosis, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2009]
UniProt Comments for CTNS
CTNS: Thought to transport cystine out of lysosomes. Defects in CTNS are the cause of cystinosis nephropathic type (CTNS). It is a form of cystinosis, a lysosomal storage disease due to defective transport of cystine across the lysosomal membrane. This results in cystine accumulation and crystallization in the cells causing widespread tissue damage. The classical nephropathic form has onset in the first year of life and is characterized by a polyuro-polydipsic syndrome, marked height-weight growth delay, generalized impaired proximal tubular reabsorptive capacity, with severe fluid-electrolyte balance alterations, renal failure, ocular symptoms and other systemic complications. Defects in CTNS are the cause of cystinosis ***** non- nephropathic type (CTNSANN). It is a form of cystinosis, a lysosomal storage disease due to defective transport of cystine across the lysosomal membrane. This results in cystine accumulation and crystallization in the cells causing widespread tissue damage. Cystinosis ***** non-nephropathic type is characterized by ocular features and a benigne course. Patients manifest mild photophobia due to conjunctival and corneal cystine crystals. Defects in CTNS are the cause of cystinosis late-onset juvenile or adolescent nephropathic type (CTNSJAN). It is a form of cystinosis, a lysosomal storage disease due to defective transport of cystine across the lysosomal membrane. This results in cystine accumulation and crystallization in the cells causing widespread tissue damage. Late-onset juvenile or adolescent nephropathic cystinosis manifests itself first at age 10 to 12 years with proteinuria due to glomerular damage rather than with the manifestations of tubular damage that occur first in infantile cystinosis. There is no excess amino aciduria and stature is normal. Photophobia, late development of pigmentary retinopathy, and chronic headaches are features. Belongs to the cystinosin family. 2 isoforms of the human protein are produced by alternative splicing.
Protein type: Membrane protein, integral; Membrane protein, multi-pass
Chromosomal Location of Human Ortholog: 17p13
Cellular Component: intermediate filament cytoskeleton; intracellular membrane-bound organelle; lysosome; lysosomal membrane; late endosome; early endosome; integral to membrane; plasma membrane; melanosome
Molecular Function: L-cystine transmembrane transporter activity
Biological Process: ATP metabolic process; melanin biosynthetic process; lens development in camera-type eye; grooming behavior; amino acid metabolic process; glutathione metabolic process; long-term memory; L-cystine transport; visual learning; brain development; cognition; ***** walking behavior
Disease: Cystinosis, Adult Nonnephropathic; Cystinosis, Late-onset Juvenile Or Adolescent Nephropathic Type; Cystinosis, Nephropathic
Product References and Citations for anti-CTNS antibody
Taranta, A., et al. Pediatr. Nephrol. 25(7):1263-1267(2010)
Bellomo, F., et al. Free Radic. Biol. Med. 48(7):865-872(2010)
Kumar, A., et al. J. Biosci. 35(1):21-25(2010)
Aldahmesh, M.A., et al. Ophthalmic Genet. 30(4):185-189(2009)
Macias-Vidal, J., et al. Clin. Genet. 76(5):486-489(2009)
Research Articles on CTNS
1. The present data exhibit a fundament for molecular carrier detection and prenatal diagnosis of a relatively large percentage of Iranian patients suffering from NC
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.